Data / Form D filings / INFACARE PHARMACEUTICAL CORP
INFACARE PHARMACEUTICAL CORP: Form D filings
INFACARE PHARMACEUTICAL CORP, a pharmaceuticals company in Trevose, PA, filed 6 Form D notices with the SEC between 2013 and 2017. The latest, on June 7, 2017, reports $3.5 million sold of a $11 million offering to 11 investors.
Find out what INFACARE PHARMACEUTICAL CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 NESHAMINY INTERPLEX, SUITE 221, Trevose, PA, 19053
- Phone
- (267) 515-5850
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1174264
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 7, 2017 | New notice | $11,000,000 | $3,500,000 | $7,500,000 | 11 | May 24, 2017 | sec.gov |
| Nov 4, 2016 | New notice | $11,000,000 | $5,500,000 | $5,500,000 | 11 | Oct 26, 2016 | sec.gov |
| Jul 8, 2015 | New notice | $12,100,000 | $12,100,000 | $0 | 10 | Jun 24, 2015 | sec.gov |
| Dec 9, 2014 | New notice | $1,300,000 | $1,300,000 | $0 | 2 | Dec 8, 2014 | sec.gov |
| Oct 21, 2014 | New notice | $750,000 | $750,000 | $0 | 6 | Oct 20, 2014 | sec.gov |
| Mar 20, 2013 | New notice | $21,556,876 | $3,556,876 | $18,000,000 | 6 | Mar 8, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Vukovich | Director | |
| Harold Werner | Director | |
| Peter Barrett | Director | |
| Patrick Enright | Director | |
| William Crouse | Director | |
| E. Ronald Goldfuss | Executive Officer | |
| Dan Burns | Executive Officer, Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Jun 5, 2017 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what INFACARE PHARMACEUTICAL CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.